Teva and Natco have now launched generic lenalidomide capsules in four strengths – 5, 10, 15 and 25 mg – for multiple ... BMS – which acquired Celgene for $74 billion takeover of in 2019 ...
Celgene has added another new indication for its blood cancer blockbuster Revlimid, with the FDA approving ... 20% of the total and MZL adds another 10% to the tally. There are however a number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback